DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments" report to their offering.
The projected U.S. market for biodefense-related rapid pathogen detection devices is valued at $214.2 million in 2015. The total market is projected to grow at a compound annual growth rate (CAGR) of 8% from 2016 through 2021 and reach $248 million by 2016 and $364 million by 2021.
The market report organizes information from diverse sources into a cohesive unit that includes an industry overview; overview of infectious agents with detection, vaccine and treatment information; biodefense-related diagnostic tools; current research and emerging industries related to rapid pathogen identification; biodefense-related pathogen identification product patents; and a comprehensive directory of assay, sensor, vaccine and treatment companies.
It provides outlines of the political and social landscape of biodefense, focusing on the issues of surveillance, coordination of resources and financing.
Key Topics Covered:
Chapter 1: Introduction
Chapter 2: Summary
Chapter 3: Industry Overview
Chapter 4: Overview Of Infectious Agents
Chapter 5: Biodefense-Related Pathogen Detection Devices
Chapter 6: Current Research, Emerging Therapies, Patents And Market Opportunities
Chapter 7: U.S. Agencies And Their Purposes
Chapter 8: Company Directory
For more information visit http://www.researchandmarkets.com/research/6lfzfn/the_u_s_market